Mouse genetics and proteomic analyses demonstrate a critical role for complement in a model of DHRD/ML, an inherited

Donita L Garland1, Rosario Fernandez-Godino, Inderjeet Kaur

  • 1Ocular Genomics Institute and.

Human Molecular Genetics
|August 15, 2013
PubMed

Insights

The complement system plays a critical role in the formation of basal deposits, an early stage of macular degeneration. Inhibiting complement activity in a mouse model prevented these deposits, suggesting a therapeutic target for vision loss.

Area of Science:

  • Ophthalmology
  • Genetics
  • Immunology

Background:

  • Macular degenerations are leading causes of vision loss, with genetic factors and complement system involvement implicated in their pathogenesis.
  • Drusen formation is a hallmark of macular degeneration, preceded by the development of basal deposits.
  • The precise mechanisms linking the complement system to macular degeneration remain unclear.

Purpose of the Study:

  • To investigate the role of the complement system in the earliest stages of macular degeneration, specifically basal deposit formation.
  • To utilize a mouse model of Doyne Honeycomb Retinal Dystrophy/Malattia Leventinese (DHRD/ML) to study basal deposit development.

Main Methods:

  • Studied gene-targeted Efemp1(R345W/R345W) mice, a model for DHRD/ML, which exhibit extensive basal deposits.
  • Performed proteomic analyses on Bruch's membrane/choroid to characterize basal deposit composition and identify immune-related proteins.
  • Generated Efemp1(R345W/R345W):C3(-/-) double-mutant mice to genetically ablate the complement response.

Main Results:

  • Proteomic analysis revealed basal deposits consist of abnormal amounts of extracellular matrix (ECM) components and altered immune-related proteins, including complement factors.
  • Genetic ablation of the complement response in double-mutant mice significantly inhibited basal deposit formation.
  • These findings highlight the critical involvement of the complement system in the pathogenesis of basal deposits.

Conclusions:

  • The complement system plays a crucial role in the formation of basal deposits, an early event in certain macular degenerations.
  • Complement-mediated recognition of abnormal extracellular matrix may drive basal deposit formation in DHRD/ML and potentially other macular degenerations.
  • Targeting the complement system could offer a therapeutic strategy for preventing vision loss associated with macular degeneration.